日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Talimogene laherparepvec and atezolizumab in HER2-negative breast cancer following neoadjuvant chemotherapy: a window-of-opportunity phase II trial (SOLTI-1503 PROMETEO)

Talimogene laherparepvec 和 atezolizumab 在新辅助化疗后 HER2 阴性乳腺癌中的应用:一项机会窗口 II 期试验 (SOLTI-1503 PROMETEO)

Pascual, Tomás; Vidal, Maria; Cejalvo, Juan M; Vega, Estela; Sanfeliu, Esther; Villacampa, Guillermo; Ganau, Sergi; Parreño, Ana María Julve; Zamora, Esther; Miranda, Ignacio; Delgado, Ana; Bermejo, Begoña; Seguí, Elia; Brasó-Maristanty, Fara; de la Cruz-Merino, Luis; Juan, Manel; Galván, Patricia; Gonzàlez-Farré, Xavier; Chillara, Samyukta; Villagrasa, Patricia; Pfefferle, Adam D; O'Connell, Constandina E; Ferrero-Cafiero, Juan M; Oliveira, Mafalda; Perou, Charles M; Prat, Aleix

Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast Cancer

HER2DX基因组检测与HER2阳性乳腺癌生物学和病理特征的关联

Sanfeliu, Esther; Martínez-Romero, Anabel; Marín-Aguilera, Mercedes; Cobo, Sandra; González-Farré, Blanca; Hernandez-Illan, Eva; Jares, Pedro; Puig-Butillé, Joan Antón; Muñoz, Montserrat; Gómez-Bravo, Raquel; Tapia, Marta; Tebar, Cristina; Saura, Cristina; Escrivà-de-Romaní, Santiago; Soberino, Jesús; Cortés, Javier; Morales, Serafin; Amillano, Kepa; Paré, Laia; Villagrasa, Patricia; Buckingham, Wesley; Pardo, Francisco; Parker, Joel S; Brasó-Maristany, Fara; Ciruelos, Eva; Sánchez-Bayona, Rodrigo; Martinez-Sáez, Olga; Cejalvo, Juan Miguel; Prat, Aleix

Validation of the HER2DX genomic test in first-line advanced HER2-positive breast cancer treated with trastuzumab, pertuzumab, and taxane

验证 HER2DX 基因组检测在接受曲妥珠单抗、帕妥珠单抗和紫杉烷一线治疗的 HER2 阳性晚期乳腺癌患者中的应用价值

Kubeczko, Marcin; Cobo, Sandra; Sanchez-Bayona, Rodrigo; Pyciński, Bartłomiej; Soberino, Jesús; Chmielik, Ewa; Sanfeliu, Esther; Rey, Maria; Pardo, Francisco; Aguirre, Angela; Castillo, Oleguer; Lesniak, Aleksandra; Oczko-Wojciechowska, Malgorzata; Carcelero, Esther; Adamo, Barbara; Vidal, Maria; Bergamino, Milana; Maues, Julia; Villacampa, Guillermo; Paré, Laia; Villagrasa, Patricia; Ciruelos, Eva; Prat, Aleix; Jarzab, Michal; Brasó-Maristany, Fara

Corrigendum to 'Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis(') (JHEP Reports 7 [2025] 101611)

对“对于同时患有急性静脉曲张出血和严重酒精相关性肝炎的高危患者,应考虑预防性TIPS”的更正(JHEP Reports 7 [2025] 101611)

Rudler, Marika; Hernández-Gea, Virginia; Larrue, Hélène; Bouzbib, Charlotte; Procopet, Bogdan; Baiges, Anna; Turon, Fanny; Villanueva, Candido; Albillos, Agustin; Tapias, Edilmar Alvarado; Gluud, Lise Lott; Praktiknjo, Michael; Genesca, Joan; Ventura-Cots, Meritxell; Villagrasa, Ares; Rodrigues, Susanna; Mouri, Sarah; Giráldez-Gallego, Álvaro; Ridaura, Helena Masnou; Laleman, Wim; Bureau, Christophe; Robic, Marie-Angèle; Hartl, Lukas; Tellez, Luis; Zipprich, Alexander; Canete, Nuria; Sultanik, Philippe; Deckmyn, Olivier; Mandorfer, Mattias; Senzolo, Marco; Schepis, Filippo; Tripathi, Dhiraj; Garcia Pagan, Juan Carlos; Thabut, Dominique

Evaluation of the uncertainty in calculating nanodosimetric quantities due to the use of different interaction cross sections in Monte Carlo track structure codes

评估由于蒙特卡罗径迹结构代码中使用不同的相互作用截面而导致的纳米剂量学量计算不确定性。

Villagrasa, Carmen; Baiocco, Giorgio; Chaoui, Zine-El-Abidine; Dingfelder, Michael; Incerti, Sébastien; Kundrát, Pavel; Kyriakou, Ioanna; Matsuya, Yusuke; Kai, Takeshi; Parisi, Alessio; Perrot, Yann; Pietrzak, Marcin; Schuemann, Jan; Rabus, Hans

The role of personality traits and moral disengagement in academic dishonesty: An analysis of the big five and the dark tetrad

人格特质和道德脱离在学术不端行为中的作用:基于五大人格特质和黑暗四元组的分析

Sánchez-García, Julia; Cebrián, Jorge; Fernández-Del-Río, Elena; Ramos-Villagrasa, Pedro J

Finding More in Less: Precision Medicine for Pancreatic Cancer Using Residual Cytology Samples

以更少的资源获得更多:利用残余细胞学样本进行胰腺癌精准医疗

Antón-Peñalver, Raquel; Ortega, María; González-Muñoz, Jose Francisco; Compañ, Desamparados; Galindo, Constanza; Arnau, Clara; Huerta, Marisol; Gambardella, Valentina; Roda, Desamparados; Villagrasa, Rosana; Sanchiz, Vicente; Peña, Andrés; Muñoz-Forner, Elena; Mora Oliver, Isabel; Sabater, Luis; Cervantes, Andrés; Ferrández, Antonio; Alfaro-Cervelló, Clara

HER2DX in older patients with HER2-positive early breast cancer: extended follow-up from the RESPECT trial of trastuzumab ± chemotherapy

HER2DX 在老年 HER2 阳性早期乳腺癌患者中的应用:曲妥珠单抗±化疗 RESPECT 试验的长期随访结果

Nozawa, Kazuki; Sawaki, Masataka; Uemura, Yukari; Tsuneizumi, Michiko; Takano, Toshimi; Gondo, Naomi; Hara, Fumikata; Harao, Michiko; Toyama, Tatsuya; Taira, Naruto; Vivancos, Ana; Perou, Charles M; Sanfeliu, Esther; Brasó-Maristany, Fara; Parker, Joel S; Buckingham, Wesley; Paré, Laia; Villacampa, Guillermo; Marín-Aguilera, Mercedes; Villagrasa, Patricia; Prat, Aleix; Iwata, Hiroji

HER2DX in HER2-positive inflammatory breast cancer: correlative insights and comparative analysis with noninflammatory breast cancers

HER2阳性炎性乳腺癌中的HER2DX:相关性分析及与非炎性乳腺癌的比较分析

Lynce, F; Martínez-Sáez, O; Walbaum, B; Brasó-Maristany, F; Waks, A G; Villagrasa, P; Villacampa Javierre, G; Sanfeliu, E; Galván, P; Paré, L; Anderson, L M; Perou, C M; Parker, J S; Vivancos, A; DiLullo, M K; Pernas, S; Winer, E P; Overmoyer, B; Mittendorf, E A; Bueno-Muiño, C; Martín, M; Prat, A; Tolaney, S M

Palbociclib and trastuzumab for HER2-positive metastatic breast cancer: final overall survival results of cohort A and B of SOLTI-1303-PATRICIA trial

帕博西尼联合曲妥珠单抗治疗HER2阳性转移性乳腺癌:SOLTI-1303-PATRICIA试验A组和B组的最终总生存期结果

Pascual, T; Villacampa, G; Oliveira, M; Escrivá-de-Romaní, S; Pernas, S; Paré, L; Adamo, B; Martínez, E; Cortés, J; Perelló, A; Galan, M; Melé, M; Villanueva, L; Gonzalez-Rodriguez, M; Tolosa, P; González-Farré, B; Galván, P; Canes, J; Nuciforo, P; Ferrero-Cafiero, J M; González-Farré, X; Villagrasa, P; Prat, A; Ciruelos, E